Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effectiveness of an Online Psychological Support Program for Mothers of Children With Autism

7. August 2026 aktualisiert von: Sabri Hergüner

Effectiveness of an Online Psychological Support Program for Mothers of Children Diagnosed With Autism Spectrum Disorder: A Controlled Study

The aim of this study to evaluate the effectiveness of an online psychological support program for mothers of children diagnosed with Autism Spectrum Disorder (ASD). In this study, investigators aim to assess the impact of the psychological support program on mothers' mental health and parenting stress levels, investigate the factors associated with changes in parenting stress, and examine the effect of reduced parenting stress on children's behavioral problems and the severity of autism.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties in social communication and interaction, repetitive behaviors, and restricted interests. Since ASD is a developmental disorder that affects language, speech, cognitive, social, and emotional skills, raising a child with ASD can be a challenging experience for parents. Parents of children with ASD generally experience higher levels of stress, anxiety, and depression compared to parents of typically developing children, and their chronic stress levels are also higher compared to parents of children with developmental delays. A longitudinal study has shown that acceptance plays a protective role in parents' adaptation to an autism diagnosis and is associated with lower levels of depression both cross-sectionally and over time. In contrast, caregivers with increasing levels of self-blame and hopelessness toward the diagnosis have been observed to experience worsened mental health and decreased life satisfaction.

Acceptance and Commitment Therapy (ACT) is a form of cognitive-behavioral therapy that focuses on acceptance and mindfulness. This therapeutic approach aims to increase psychological flexibility by altering individuals' relationship with events and their function through six flexible hexagonal concepts (acceptance, defusion, present moment contact, context-based self, values, and value-driven behavior). A review study conducted in 2022 demonstrated that ACT interventions for parents of children with ASD can be beneficial.

The rationale for this study stems from the need for approaches to improve the mental health of mothers of children diagnosed with ASD, as these mothers experience higher levels of stress, anxiety, and depression. The literature on the effects of ACT-based interventions on parents' psychological well-being is limited. Research on the effectiveness of ACT-based psychological support programs for parents of children with ASD is still in its early stages. Therefore, it is important to evaluate how ACT-based psychological support programs affect the anxiety, stress, and depression levels of parents of children with ASD, the factors related to these effects, and how reductions in parenting stress influence children's behavioral problems and autism severity.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

181

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • The participant must have at least one child with a clinically confirmed diagnosis of ASD.
  • The child with autism must be between 2 and 11 years of age.
  • Parents must be able to speak and read Turkish sufficiently.
  • Parents must agree not to participate in any other mental health support program during the study.

Exclusion Criteria:

  • Incomplete completion of the scales
  • The child with autism is not between the ages of 2 and 11
  • Parents are participating in another mental health support program.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: The intervention group
Parents in the intervention group will participate in a 5-week Online Acceptance and Commitment Therapy (ACT) Based Parent Support Program. Six weeks after the program completion, they will attend a follow-up session for additional support.
Verhalten: Online Acceptance and Commitment Therapy-Based Parent Support Program
The sessions are structured around the core ACT skills (contact with the present moment, acceptance, defusion, values, commitment, and contextual self). Each session includes stages of information sharing, exemplification, meditation practice, feedback, and group discussion. The topics and practices are derived from standardized content commonly used in ACT groups. After each session, home exercises related to the weekly topic are provided, and feedback on these exercises is gathered from participants at the beginning of the next session. Audio recordings for the meditation practices are created and sent to participants via email.
Kein Eingriff: The control group
Participants assigned to the control group will not receive the intervention during the study period. They will remain on a waitlist and will receive the online ACT-based parent support program after completion of the post-intervention assessment.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Changes in Depression, Anxiety, and Stress
Zeitfenster: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
The Depression Anxiety Stress Scales-21 (DASS-21) is a 21-item self-report questionnaire assessing symptoms of depression, anxiety, and stress. Each item is rated on a 4-point Likert scale (0-3). Scores for each subscale range from 0 to 42, with higher scores indicating greater symptom severity. The total score ranges from 0 to 126, with higher scores indicating greater overall psychological distress. The scale will be administered at baseline (T1), at the end of the 5-week intervention (T2), and at the 6-week follow-up (T3) in the intervention group. The control group will be assessed at T1 and T2 only. Changes in scores from T1 to T2 will be compared between groups using analysis of covariance (ANCOVA), controlling for baseline values. Within-group changes across T1, T2, and T3 will also be evaluated in the intervention group.
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Changes in Parenting Stress
Zeitfenster: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
The 15-item version of the Parent Stress Scale (PSS) was used to assess parenting-related stress. Items are rated on a 5-point Likert scale. Total scores range from 15 to 75, with higher scores indicating greater parenting stress. The scale was administered at baseline (T1), at the end of the 5-week intervention (T2), and at 6-week follow-up (T3) in the intervention group. The control group was assessed at T1 and T2 only. Changes in scores from T1 to T2 will be compared between the intervention and control groups using analysis of covariance (ANCOVA), controlling for baseline values. Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
Changes in Autistic Traits (Autism Spectrum Quotient-10, AQ-10)
Zeitfenster: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
The Autism Spectrum Quotient-10 (AQ-10) was used to assess autistic traits. The scale consists of 10 items scored in a binary format (0-1). Total scores range from 0 to 10, with higher scores indicating greater levels of autistic traits. The scale was administered at T1, T2, and T3 in the intervention group, and at T1 and T2 in the control group. Changes in scores from T1 to T2 will be compared between groups using ANCOVA, controlling for baseline values. Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
Changes in Psychological Flexibility (Acceptance and Action Questionnaire-II, AAQ-II)
Zeitfenster: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
The Acceptance and Action Questionnaire-II (AAQ-II) was used to assess psychological flexibility. The scale consists of 7 items rated on a 7-point Likert scale. Total scores range from 7 to 49, with higher scores indicating greater psychological inflexibility (i.e., lower psychological flexibility). The scale was administered at T1, T2, and T3 in the intervention group, and at T1 and T2 in the control group. Changes in scores from T1 to T2 will be compared between groups using ANCOVA, controlling for baseline values. Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
Changes in Cognitive Fusion (Cognitive Fusion Questionnaire, CFQ)
Zeitfenster: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
The Cognitive Fusion Questionnaire (CFQ) was used to assess cognitive fusion. The scale consists of 7 items rated on a 7-point Likert scale. Total scores range from 7 to 49, with higher scores indicating greater cognitive fusion. The scale was administered at T1, T2, and T3 in the intervention group, and at T1 and T2 in the control group. Changes in scores from T1 to T2 will be compared between groups using ANCOVA, controlling for baseline values. Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
Changes in Autism Severity (Social Responsiveness Scale, SRS)
Zeitfenster: Baseline (T1), End of Week 5 (T2)
The Social Responsiveness Scale (SRS) was used to assess autism-related social impairments in children. The scale consists of 65 items rated on a Likert scale. Total scores range from 0 to 195, with higher scores indicating greater severity of autism symptoms. The scale was administered at baseline (T1) and at the end of the 5-week intervention (T2) in both groups. Changes in scores from T1 to T2 will be compared between the intervention and control groups using ANCOVA, controlling for baseline values.
Baseline (T1), End of Week 5 (T2)
Changes in Behavioral Problems (Abnormal Behavior Checklist, ABC)
Zeitfenster: Baseline (T1), End of Week 5 (T2)
The Abnormal Behavior Checklist (ABC) was used to evaluate behavioral problems in children. The scale consists of 58 items rated on a 4-point Likert scale. Total scores range from 0 to 174, with higher scores indicating greater severity of behavioral problems. The scale was administered at T1 and T2 in both groups. Changes in scores from T1 to T2 will be compared between the intervention and control groups using ANCOVA, controlling for baseline values.
Baseline (T1), End of Week 5 (T2)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Sabri Hergüner

Mitarbeiter

Herguner Therapy Private Clinic

Ermittler

  • Studienleiter: Sabri Hergüner, Assoc.Prof., Herguner Tharapy Private Clinic

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

5. Januar 2025

Primärer Abschluss (Tatsächlich)

28. Februar 2025

Studienabschluss (Tatsächlich)

30. April 2025

Studienanmeldedaten

Zuerst eingereicht

25. Dezember 2024

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

7. August 2026

Zuerst gepostet (Tatsächlich)

11. August 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

11. August 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

7. August 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Schlüsselwörter

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • ACTParentsAutism

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be shared due to ethical and confidentiality restrictions. The data include sensitive information from parents and children, and the informed consent obtained did not include permission for data sharing.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren